132 related articles for article (PubMed ID: 9736437)
1. New evidence on the prevention of cardiovascular events in hypertensive patients with type 2 diabetes.
Pahor M; Psaty BM; Furberg CD
J Cardiovasc Pharmacol; 1998; 32 Suppl 2():S18-23. PubMed ID: 9736437
[TBL] [Abstract][Full Text] [Related]
2. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
Tatti P; Pahor M; Byington RP; Di Mauro P; Guarisco R; Strollo G; Strollo F
Diabetes Care; 1998 Apr; 21(4):597-603. PubMed ID: 9571349
[TBL] [Abstract][Full Text] [Related]
3. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
Pahor M; Psaty BM; Alderman MH; Applegate WB; Williamson JD; Furberg CD
Diabetes Care; 2000 Jul; 23(7):888-92. PubMed ID: 10895836
[TBL] [Abstract][Full Text] [Related]
5. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hypertensive patients with diabetes.
Pahor M; Psaty BM; Furberg CD
Lancet; 1998 Mar; 351(9104):689-90. PubMed ID: 9504510
[No Abstract] [Full Text] [Related]
7. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial.
Estacio RO; Schrier RW
Am J Cardiol; 1998 Nov; 82(9B):9R-14R. PubMed ID: 9822137
[TBL] [Abstract][Full Text] [Related]
9. The Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) and combination therapies.
Pahor M; Tatti P
Am J Cardiol; 1999 Mar; 83(5):819-20. PubMed ID: 10080455
[No Abstract] [Full Text] [Related]
10. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
Jamerson K; Weber MA; Bakris GL; Dahlöf B; Pitt B; Shi V; Hester A; Gupte J; Gatlin M; Velazquez EJ;
N Engl J Med; 2008 Dec; 359(23):2417-28. PubMed ID: 19052124
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication.
Jeffers BW; Robbins J; Bhambri R; Wajsbrot D
Am J Ther; 2015; 22(5):322-41. PubMed ID: 25738570
[TBL] [Abstract][Full Text] [Related]
12. Calcium antagonists and cardiovascular risk in diabetes.
Parving HH
Am J Cardiol; 1998 Nov; 82(9B):42R-44R. PubMed ID: 9822145
[TBL] [Abstract][Full Text] [Related]
13. Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients.
Fogari R; Preti P; Zoppi A; Rinaldi A; Corradi L; Pasotti C; Poletti L; Marasi G; Derosa G; Mugellini A; Voglini C; Lazzari P
Am J Hypertens; 2002 Dec; 15(12):1042-9. PubMed ID: 12460699
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity of hypertension and diabetes: the fosinopril versus amlodipine cardiovascular events trial (FACET).
Sowers JR
Am J Cardiol; 1998 Nov; 82(9B):15R-19R. PubMed ID: 9822138
[TBL] [Abstract][Full Text] [Related]
15. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
16. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
17. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
Nissen SE; Tuzcu EM; Libby P; Thompson PD; Ghali M; Garza D; Berman L; Shi H; Buebendorf E; Topol EJ;
JAMA; 2004 Nov; 292(18):2217-25. PubMed ID: 15536108
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
Berl T; Hunsicker LG; Lewis JB; Pfeffer MA; Porush JG; Rouleau JL; Drury PL; Esmatjes E; Hricik D; Parikh CR; Raz I; Vanhille P; Wiegmann TB; Wolfe BM; Locatelli F; Goldhaber SZ; Lewis EJ;
Ann Intern Med; 2003 Apr; 138(7):542-9. PubMed ID: 12667024
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.
Hanon O; Boully C; Caillard L; Labourée F; Cochiello S; Chaussade E
Am J Hypertens; 2015 Aug; 28(8):1064-71. PubMed ID: 25628416
[TBL] [Abstract][Full Text] [Related]
20. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]